These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23371862)

  • 1. Lack of nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2): consequences for mouse bladder development and function.
    Hicks AN; Campeau L; Burmeister D; Bishop CE; Andersson KE
    Neurourol Urodyn; 2013 Nov; 32(8):1130-6. PubMed ID: 23371862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo.
    Hicks AN; Lorenzetti D; Gilley J; Lu B; Andersson KE; Miligan C; Overbeek PA; Oppenheim R; Bishop CE
    PLoS One; 2012; 7(10):e47869. PubMed ID: 23082226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.
    Lukacs M; Gilley J; Zhu Y; Orsomando G; Angeletti C; Liu J; Yang X; Park J; Hopkin RJ; Coleman MP; Zhai RG; Stottmann RW
    Exp Neurol; 2019 Oct; 320():112961. PubMed ID: 31136762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo.
    Slivicki RA; Ali YO; Lu HC; Hohmann AG
    PLoS One; 2016; 11(1):e0147620. PubMed ID: 26808812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of peripheral and CNS axon defects in mice lacking NMNAT2.
    Gilley J; Adalbert R; Yu G; Coleman MP
    J Neurosci; 2013 Aug; 33(33):13410-24. PubMed ID: 23946398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of NMNAT2 compromise axon development and survival.
    Gilley J; Mayer PR; Yu G; Coleman MP
    Hum Mol Genet; 2019 Feb; 28(3):448-458. PubMed ID: 30304512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2.
    Mayer PR; Huang N; Dewey CM; Dries DR; Zhang H; Yu G
    J Biol Chem; 2010 Dec; 285(51):40387-96. PubMed ID: 20943658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-function approach using mouse retinal explants showed pivotal roles of Nmnat2 in early and middle stages of retinal development.
    Kuribayashi H; Katahira M; Aihara M; Suzuki Y; Watanabe S
    Mol Biol Cell; 2023 Jan; 34(1):ar4. PubMed ID: 36322391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide Mononucleotide Adenylyltransferase 2 maintains neuronal structural integrity through the maintenance of golgi structure.
    Pottorf T; Mann A; Fross S; Mansel C; Vohra BPS
    Neurochem Int; 2018 Dec; 121():86-97. PubMed ID: 30278188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of palmitoyltransferase and thioesterase enzymes that control the subcellular localization of axon survival factor nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2).
    Milde S; Coleman MP
    J Biol Chem; 2014 Nov; 289(47):32858-70. PubMed ID: 25271157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy.
    Ljungberg MC; Ali YO; Zhu J; Wu CS; Oka K; Zhai RG; Lu HC
    Hum Mol Genet; 2012 Jan; 21(2):251-67. PubMed ID: 22027994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.
    Milde S; Fox AN; Freeman MR; Coleman MP
    Sci Rep; 2013; 3():2567. PubMed ID: 23995269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.
    Milde S; Gilley J; Coleman MP
    Bioarchitecture; 2013; 3(5):133-40. PubMed ID: 24284888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons.
    Ali YO; Bradley G; Lu HC
    Sci Rep; 2017 Mar; 7():43846. PubMed ID: 28266613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMNAT2: An important metabolic enzyme affecting the disease progression.
    Li W; Gao M; Hu C; Chen X; Zhou Y
    Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated Nmnat2 causes neuronal death and increases seizure susceptibility in temporal lobe epilepsy.
    Wu H; Meng Q; Zhang Y; Li H; Liu Y; Dong S; Liu B; Zhang H
    Brain Res Bull; 2021 Feb; 167():1-10. PubMed ID: 33248200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fgfr2 is integral for bladder mesenchyme patterning and function.
    Walker KA; Ikeda Y; Zabbarova I; Schaefer CM; Bushnell D; De Groat WC; Kanai A; Bates CM
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F888-98. PubMed ID: 25656370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional changes in bladder tissue from type III collagen-deficient mice.
    Stevenson K; Kucich U; Whitbeck C; Levin RM; Howard PS
    Mol Cell Biochem; 2006 Feb; 283(1-2):107-14. PubMed ID: 16444592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
    Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
    Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship.
    Brunetti L; Di Stefano M; Ruggieri S; Cimadamore F; Magni G
    Protein Sci; 2010 Dec; 19(12):2440-50. PubMed ID: 20954240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.